Google's AI program: Building better algorithms for detecting eye diseaseMarch 13, 2018
SAN FRANCISCO - March 13, 2017 - The ability of artificial intelligence (AI) to help screen patients for a common diabetic eye disease gains momentum with a new study published online today in Ophthalmology, the journal of the American Academy of Ophthalmology. Lily Peng, M.D., Ph.D., and her colleagues at Google AI research group, show that they could improve their disease detecting software by using a small subset of images adjudicated by ophthalmologists who specialize in retinal diseases. The specialists' input was then used to improve their computer's performance so that it was roughly equal to that of individual retinal specialists.
More than 29 million Americans have diabetes, and are at risk for diabetic retinopathy, a potentially blinding eye disease. People often don't notice changes in their vision in the disease's early stages. But as it progresses, diabetic retinopathy usually causes vision loss that in many cases cannot be reversed. That's why it's so important that people with diabetes have yearly screenings.
In earlier research, Dr. Peng and her team used neural networks--complex mathematical systems for identifying patterns in data--to recognize diabetic retinopathy. They fed thousands of retinal scans into these neural networks to teach them to "see" tiny hemorrhages and other lesions that are early warning signs of retinopathy. Dr. Peng showed the software worked roughly as well as human experts.
But Dr. Peng is interested in developing a system that would be good enough for her grandmother. So, to improve the accuracy of the software, she included the input of retina specialists, ophthalmologists who specialize in diseases of the retina.
"For my grandma, I would love to have a panel of subspecialists who actually treat the disease, to sit and debate her case, giving their opinion," Dr. Peng said. "But that is really expensive and it's hard to do. So how do you build an algorithm that gets close to this?"
To tease out how this could be done, Dr. Peng compared the performance of the original algorithm with manual image grading by either a majority decision of three general ophthalmologists, or a consensus grading by three retinal specialists.
The grading of diabetic retinopathy can be a complex process that requires the identification and quantification of fine features such as small aneurysms and hemorrhages. As a result, there can be a fair amount of variability among physicians examining images, looking for disease.
The retina specialists graded the images separately, then worked together to resolve any disagreements. Their review and subsequent consensus diagnosis offered considerable insight into the grading process, helping to correct errors such as artifacts caused by dust spots, distinguishing between different types of hemorrhages, and creating more precise definitions for "gray areas" that make it difficult to make a definitive diagnosis. At the end of the process, the retina specialists indicated that the precision used in the decision process was above that typically used in everyday clinical practice.
Using these specialist-graded images, Dr. Peng could then fine-tune the software, which improved their model's performance and improved detection of disease.
"We believe this work provides a basis for further research and raises the bar for reference standards in the field of applying machine learning to medicine," Dr. Peng said.
The American Academy of Ophthalmology is the world's largest association of eye physicians and surgeons. A global community of 32,000 medical doctors, we protect sight and empower lives by setting the standards for ophthalmic education and advocating for our patients and the public. We innovate to advance our profession and to ensure the delivery of the highest-quality eye care. Our EyeSmart® program provides the public with the most trusted information about eye health. For more information, visit aao.org.
Ophthalmology, the official journal of the American Academy of Ophthalmology, publishes original, peer-reviewed, clinically-applicable research. Topics include the results of clinical trials, new diagnostic and surgical techniques, treatment methods, technology assessments, translational science reviews and editorials. For more information, visit http://www.aaojournal.org.
American Academy of Ophthalmology
Related Retinopathy Articles:
This new study revealed how the loss of pericytes aggravates the retinal environment and function in a mouse experimental model.
Can a large-scale, primary care-based teleretinal diabetic retinopathy screening (TDRS) program reduce wait times for screening and improve the timeliness of care in the Los Angeles County Department of Health Services, the largest publicly operated county safety net health care system in the United States?
Many youths with type 1 and 2 diabetes are not receiving eye examinations as recommended to monitor for diabetic retinopathy, according to a study published online by JAMA Ophthalmology.
Specific cells in the retina trigger inflammation and vision impairment associated with diabetes, according to new research out of Case Western Reserve University School of Medicine.
Mary Elizabeth Hartnett, M.D., and colleagues at the John A.
A two-drug cocktail provided better protection against diabetes-related vision loss than a single drug during testing in rat models, a team of University of Florida Health and Dutch researchers has found.
A mini-symposium published in the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) provides important insights into new techniques and treatments that show promise for eliminating retinopathy of prematurity (ROP) throughout the world.
A more powerful version of an anti-inflammatory molecule already circulating in our blood may help protect our vision in the face of diabetes.
In an evaluation of retinal photographs from adults with diabetes, an algorithm based on deep machine learning had high sensitivity and specificity for detecting referable diabetic retinopathy, according to a study published online by JAMA.
A study sheds new understanding on the mechanisms of the diabetic retinopathy -- which is the most prominent complication of diabetes and the leading cause of blindness in working age individuals -- as it uncovered a program of accelerated aging of the neurons, blood vessels and immune cells of the retina in areas where blood vessels had been damaged.
Related Retinopathy Reading:
Small-Gauge Vitrectomy for Diabetic Retinopathy
by Ulrich Spandau (Author), Zoran Tomic (Author)
This book describes step by step how to operate on the patient with diabetic retinopathy. After thorough explanation of surgical planning, including the potential need to perform individual procedures at different time points, each stage of the vitrectomy is clearly documented with the aid of color photographs and drawings as well as online surgical videos. Variations in approach are described that are potentially of value, depending on whether one is dealing with a straightforward diabetic retinopathy or a difficult case of tractional retinal detachment. In the second part of the book, a... View Details
Retinopathy of Prematurity: Current Diagnosis and Management
by Andrés Kychenthal B. (Editor), Paola Dorta S. (Editor)
This clinically oriented book is devoted to the diagnosis and treatment of retinopathy of prematurity (ROP), a leading cause of childhood blindness. World-renowned experts in the field discuss epidemiologic and pathogenic aspects of the disease. The staging and classification of ROP are explained in detail, and guidance is provided on appropriate anesthesia. The state of the art in imaging of ROP is described and illustrated, with coverage of the advances in ophthalmic imaging technology and telemedicine that have revolutionized pediatric retinal examinations and contributed significantly in... View Details
by Bruno, M.D. Lumbroso (Author), Marco, M.D. Rispoli (Author), Maria Cristina, M.D., Ph.D. Savastano (Author)
Diabetic Retinopathy is a concise guide to the condition caused by complications of diabetes, which can eventually lead to blindness. The book is edited by a team of experts from the Italian Macular Centre in Rome, led by Prof Bruno Lumbroso. Divided into ten chapters, the book begins with basic information on diabetes and diabetic retinopathy. Further chapters demonstrate how to read and interpret different forms of imaging, including fluorescein angiography, cross-section OCT, and `en-face' OCT. Information on the use of the most recent OCT angiography imaging techniques brings this book... View Details
Diabetic Retinopathy: Evidence-Based Management
by David J. Browning (Editor)
Contains information from the Diabetic Retinopathy Clinical Research network not to be found in other published works
Evidence-based approach includes material labeled with level of supporting evidence and many clinical examples
Includes discussions of area of controversyView Details
Hydroxychloroquine and Chloroquine Retinopathy
by David J. Browning (Author)
Malpractice settlements are large for undetected hydroxychloroquine and chloroquine toxicity which, if untreated, can lead to permanent loss of central vision. Knowledge of the ocular toxicity of these drugs has increased during the past fifty years as their use has expanded. Hydroxychloroquine and Chloroquine Retinopathy is the first single-source book on the subject and is essential for the practicing ophthalmologists, rheumatologists, dermatologists, and internists who prescribe these drugs. It covers clinical topics such as signs and symptoms of toxicity, toxicity screening,... View Details
Diabetic Retinopathy: From Diagnosis to Treatment
by David S. Boyer MD (Author), Homayoun Tabandeh MD (Author)
The most common eye disease among those with type 1 or type 2 diabetes is diabetic retinopathy and this book explains the disease, how it develops, and options for treatment. Affecting more than five million Americans, the disease is caused by damage to the tiny blood vessels of the retina as the result of uncontrolled blood sugars, and is a leading cause of blindness. Diabetic retinopathy cannot be cured, however the onset can be delayed and the risk of progression can be reduced by keeping tight controls on glucose levels and making the right... View Details
Current Management of Diabetic Retinopathy, 1e
by Caroline R. Baumal MD (Author), Jay S. Duker MD (Author)
Stay current with recent progress in the field of diabetic retinopathy management with this practical resource by Drs. Caroline R. Baumal and Jay S. Duker. Concise, highly illustrated coverage includes summaries of the latest evidence and expert guidance on the rationale for each therapeutic option.Features a wealth of information for ophthalmologists, retinal specialists, and trainees on current management of this increasingly common condition.
Diabetic Retinopathy: The Essentials is written for general ophthalmologists and optometrists as well as family practitioners, diabetologists, and internists who encounter diabetic patients on a daily basis. It focuses on the diagnosis and management of diabetic retinopathy from the point of view of the retinal specialist.
The book begins with the epidemiology, anatomy, and pathophysiology of diabetic retinopathy, and then covers important topics such as classification issues, diagnostic testing, examination techniques, new treatment modalities, patient management,... View Details
A Practical Manual of Diabetic Retinopathy Management (Practical Manual of Series)
by Peter H. Scanlon (Editor), Ahmed Sallam (Editor), Peter van Wijngaarden (Editor)
The incidence of diabetes is increasing worldwide at an alarming rate, and diabetic retinopathy is one of the most significant complications of diabetes. Packed with outstanding retinal photos, the second edition of this one-stop clinical manual offers a comprehensive overview of the diagnosis, treatment and long–term management of patients with diabetic eye disease.
Edited and authored by world-renowned experts from leading centres of excellence, A Practical Manual of Diabetic Retinopathy Management presents evidence-based guidance relevant for a... View Details
Clinical Strategies in the Management of Diabetic Retinopathy: A step-by-step Guide for Ophthalmologists
by Francesco Bandello (Editor), Marco Attilio Zarbin (Editor), Rosangela Lattanzio (Editor), Ilaria Zucchiatti (Editor)
With the advent of effective treatments for diabetic retinopathy (DR), a new era in the management of DR has been opened up. Amid the deluge of approved treatments and promising new strategies, however, clinicians may find it difficult to choose the appropriate practice in each individual case. The purpose of this easy-to-use and richly illustrated manual is to assist ophthalmologists in making decisions in the entire management of DR based on the best available evidence. Practical and complete recommendations are provided to guide clinicians in diagnosis, decision-making, and treatment. The... View Details